- The project marks the start of construction of Resonetics’ third production facility in Costa Rica, expected to open in 2027
- The expansion will generate 300 new jobs
Alajuela, February 24, 2026. With an initial investment of approximately $15 million, Resonetics, a company specializing in advanced engineering and manufacturing solutions for the medical device industry, has begun construction of its third manufacturing plant in Coyol Free Zone, Costa Rica. This expansion will strengthen specialized capabilities and generate 300 new jobs.
“We are excited to announce the latest expansion of our Costa Rica operations. Our investment here is a direct result of the success we have had serving our global customer base from Costa Rica over the past 10 years. We have more than 500 employees dedicated to supporting our customers and their patients,” said Dave Mitchell, SVP of Operations. “Our third building will expand our technology portfolio in Costa Rica, enabling us to better serve our global customers and support Resonetics’ continued rapid growth.”
“Our expansion in Costa Rica represents a key milestone in Resonetics’ global growth strategy,” said Kevin Kelly, CEO of Resonetics. “By investing in advanced manufacturing capabilities and expanding our presence in Coyol Free Zone, we are positioning Resonetics to meet growing customer demand, accelerate innovation, and support the development of life-saving medical technologies worldwide.”
The project also includes strengthening linkages with local suppliers, as part of the company’s strategy to further integrate into Costa Rica’s productive ecosystem.
“Resonetics’ decision to further expand its presence in Costa Rica confirms the confidence of leading companies in the country’s capabilities to develop high-value advanced manufacturing. This investment strengthens the medical devices cluster, drives the creation of specialized jobs, and deepens the company’s integration with local suppliers. The Government of Costa Rica continues to work to consolidate a competitive environment that enables more companies to evolve toward increasingly sophisticated processes from our country”, said Manuel Tovar, Minister of Foreign Trade of Costa Rica.
“This new investment by Resonetics confirms that Costa Rica offers the conditions for advanced manufacturing companies to continue expanding their operations. The combination of specialized talent, productive linkages, and accumulated experience in the sector supports investments that generate new opportunities for Costa Ricans and strengthen the country’s industrial ecosystem”, said Laura López, CEO of the Trade and Investment Promotion Agency of Costa Rica (PROCOMER).
This expansion project was formally announced during a visit to Costa Rica by senior Resonetics executives to mark the start of construction. The new plant is expected to be operational in 2027.
Resonetics’ expansion takes place in the context of continued growth and transformation of Costa Rica’s manufacturing sector. According to PROCOMER, manufacturing accounted for 48% of the country’s goods exports in 2025, totaling US$10.927 billion and growing 25% compared to 2024, driven by increasingly complex and higher value-added operations.
Carlos Wong, CEO of CODE Development Group and co-developer of Coyol Free Zone, expressed strong support for Resonetics’ decision to expand within the industrial park, where it has operated successfully since 2016 following the opening of its first building.
“Coyol Free Zone has consolidated its position as the country’s leading Life Sciences ecosystem, driven by sustained attraction of strategic investments that validate our model, as well as exports exceeding US$4.44 billion annually. Companies operating in the park, such as Resonetics, grow, innovate, and scale within a dynamic, highly specialized, and constantly evolving environment, strengthening a high-value industrial hub with global reach,” said Wong.
“We congratulate Resonetics on the outstanding trajectory it has built in Costa Rica over the past 10 years,” he added.
While the precision and medical devices sector remains central to Costa Rica’s export profile, the country has diversified its manufacturing base into sectors such as electronics, chemical-pharmaceuticals, and metalworking. This growth is supported by a diversified business base, with more than 140 exporting companies in the manufacturing sector and a strong presence in international markets.
This investment reinforces the growth of the medical devices sector in Costa Rica and the generation of quality employment.
